Single-Dose Malaria Cure: Candidate Developed in South Africa
UCT Develops Potential Single-Dose Cure for Malaria
Malaria is responsible for nearly 1/4 of child deaths in sub-Saharan Africa, and sucks up stratospheric amounts of money for treatment and prevention. Indeed, Malaria is a key element in the cycle of poverty gripping rural Africa.
Researchers at the University of Cape Town (UCT) in South Africa hope to put an end to the human and financial waste with a single-dose cure for Malaria.
The Drug Discovery and Development Centre refined a series of chemical compounts originally discovered by researchers at Griffith University in Brisbane, Australia.
The treatment has cured infected animals with a single dose, and human trials are expected to begin in 2013.
Mosquitoes are the deadliest animals in the world, mainly due to the Anopheles Mosquito, which transmits Malaria to over 300 million people a year, up to three million of which are fatal. Imagine the societal effect of breaking that infection cycle.
According to the World Health Organization, there are an estimated 300 million acute cases of malaria each year globally. "This is truly a proud day for African science and African scientists. Our team is hopeful that the compound will emerge from rigorous testing as an extremely effective medicine for malaria," says Professor Kelly Chibale.